Table 2.
Correlation between the clinicopathological features and expression of HNRNPAB
| Clinicopathologic parameters |
Number of cases |
HNRNPAB immunostaining |
p value |
|
|---|---|---|---|---|
| 157 | Weak positive (n = 57) | Strong positive (n = 100) | ||
| Age (years) | ||||
| ≥60 | 89 | 33 | 56 | 0.818 |
| <60 | 68 | 24 | 44 | |
| Gender | ||||
| Male | 112 | 42 | 70 | 0.623 |
| Female | 45 | 15 | 30 | |
| Tumor size (cm) | ||||
| ≥5 | 102 | 31 | 71 | 0.036 |
| <5 | 55 | 26 | 29 | |
| Local invasion | ||||
| T1, T2 | 18 | 8 | 10 | 0.445 |
| T3, T4 | 139 | 49 | 90 | |
| Lymph node metastasis | ||||
| No | 27 | 16 | 11 | 0.006 |
| Yes | 130 | 41 | 89 | |
| TNM stage | ||||
| I, II | 34 | 18 | 16 | 0.023 |
| III, IV | 123 | 39 | 84 | |